MoneyWorks4Me

Wockhardt awarded six-month extension of agreement with UK Govt to fill-finish COVID-19 vaccines

10 Feb 2021 Evaluate

Wockhardt has been awarded a six-month extension of its agreement with the UK Government to fill-finish COVID-19 vaccines. This expands the original agreement from 18 to 24 months i.e., until August 2022 and the manufacturing will continue to be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..